RA-SURE - art photonics

Latest News

11 March 2025

Women in Photonics: Pioneers of Light and Innovation

By Stanislav Perevoschikov

On International Women’s Day, art photonics GmbH is proud to celebrate the brilliant women driving the photonics industry forward. These accomplished scientists, engineers, and leaders transform light into groundbreaking solutions that advance technology and improve lives. Did you know? At art photonics GmbH, we work alongside visionary women who are making significant contributions to fiber […]

26 February 2025

Discover our NIRaman Fiber Probe

By Stanislav Perevoschikov

We are excited to unveil the latest innovation from our FlexiSpec® family—the NIRaman Fiber Probe. This advanced fiber probe seamlessly integrates Near-Infrared (NIR) and Raman spectroscopy into a single device, providing a comprehensive understanding of your samples in real-time. Dual Spectroscopy Capabilities Harness the power of both NIR and Raman techniques simultaneously without the need […]

Latest Events

12 March 2025

Day 1 at Laser World of Photonics CHINA 2025, Shanghai

By Stanislav Perevoschikov

We are off to an exciting start in Shanghai at Laser World of Photonics CHINA 2025! Our Sales Director, Haro Fritsche, is on site alongside our fantastic distributor UniqueRay! Today, we are showcasing our innovative system solutions. Visit our booth to explore how our fiber cables and probes span the complete UV-Vis-NIR-MIR range (0.3-16 µm) […]

10 March 2025

Highlights from EPIC TechWatch at APE 2025: Advancing Photonics Innovation

By Stanislav Perevoschikov

We are excited to share the highlights from EPIC TechWatch at APE 2025 (Asia Photonics Expo). This exceptional event was organized by the outstanding team at the EPIC - European Photonics Industry Consortium. We are grateful for their dedication and hard work in delivering such a well-run experience. At art photonics GmbH, we take pride […]

Ra-Sure: Raman spectroscopy guided tumour surgery

Oral cavity cancer is a major public health issue, with annually 300.000 new cases and a 50% 5-year survival. Surgery is the mainstay of treatment, but adequate tumour removal is not achieved in 85% of the cases. This affects survival and leads to additional treatment of patients by radiotherapy or chemotherapy. The hands and eyes of the surgeon are insufficient for tumour delineation in the oral cavity. Significant improvement is needed to improve the surgical success rate.

In frames of Ra-Sure, a fully automated Raman spectroscopic device is under development to achieve complete tumour removal in oral cancer surgeries. The product will consist of a dedicated Raman-based tissue inspection device, the operational system and disposable fibre-optic needle probes

A fully automatic inspection device (Ra-Sure) that can perform differentiation between cancer and healthy oral tissues will be developed to the point where it can enter clinical trials. At the end of the project the device will enable rapid (within 15 minutes) inspection of surgically removed tissue in the operating room. As such, surgical removal will be effective in 50% instead of current 15% of the cases. The direct customers of the product will be surgeons and pathologists. As part of the go-to-market strategy, key opinion leaders in oral cancer will be addressed first.

The role of art photonics is the development of the unique Raman fibre-optic needle that can be inserted into the tissue multiple times and measure without loss of quality of the results.

Project Partners

Project Funders